Syndax Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Syndax Pharmaceuticals, Inc. (SNDX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 58.98 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-09
- Syndax Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 58.98M shares, a 14.52% increase year-over-year.
- Syndax Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 51.96M shares, a 17.68% increase year-over-year.
- Syndax Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 51.60M shares, a 27.07% increase year-over-year.
- Syndax Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 51.50M shares, a 50.02% increase year-over-year.
- Syndax Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 41.31M shares, a 35.48% increase from fiscal 2019.
- Syndax Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 30.49M shares, a 20.18% increase from fiscal 2018.
- Syndax Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 25.37M shares, a 20.83% increase from fiscal 2017.
- Syndax Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 21.00M shares, a 43.62% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 58.98M shares 10-Q · filed 2022-05-09 | |||
| 2021-09-30 | 51.96M shares 10-Q · filed 2021-11-15 | 51.78M shares derived: average of 2 quarters · filed 2021-11-15 | 51.69M shares 10-Q · filed 2021-11-15 | 50.28M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-06-30 | 51.60M shares 10-Q · filed 2021-08-09 | 51.55M shares 10-Q · filed 2021-08-09 | 49.72M shares derived: average of 3 quarters · filed 2022-05-09 | 48.33M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-03-31 | 51.50M shares 10-Q · filed 2022-05-09 | 48.78M shares derived: average of 2 quarters · filed 2022-05-09 | 47.24M shares derived: average of 3 quarters · filed 2022-05-09 | 45.58M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | 46.05M shares 10-K · filed 2021-03-12 | 45.11M shares derived: average of 2 quarters · filed 2021-11-15 | 43.61M shares derived: average of 3 quarters · filed 2021-11-15 | 41.31M shares 10-K · filed 2021-03-12 |
| 2020-09-30 | 44.16M shares 10-Q · filed 2021-11-15 | 42.38M shares derived: average of 2 quarters · filed 2021-11-15 | 39.71M shares 10-Q · filed 2021-11-15 | 37.68M shares derived: average of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | 40.61M shares 10-Q · filed 2021-08-09 | 37.47M shares 10-Q · filed 2021-08-09 | 35.53M shares derived: average of 3 quarters · filed 2021-08-09 | 34.55M shares derived: average of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | 34.33M shares 10-Q · filed 2021-05-11 | 32.98M shares derived: average of 2 quarters · filed 2021-05-11 | 32.53M shares derived: average of 3 quarters · filed 2021-05-11 | 32.30M shares derived: average of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | 31.64M shares 10-K · filed 2021-03-12 | 31.64M shares derived: average of 2 quarters · filed 2021-03-12 | 31.63M shares derived: average of 3 quarters · filed 2021-03-12 | 30.49M shares 10-K · filed 2021-03-12 |
| 2019-09-30 | 31.63M shares 10-K · filed 2021-03-12 | 31.62M shares derived: average of 2 quarters · filed 2021-03-12 | 30.10M shares 10-Q · filed 2020-11-05 | 29.27M shares derived: average of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | 31.61M shares 10-K · filed 2021-03-12 | 29.33M shares 10-Q · filed 2020-08-06 | 28.48M shares derived: average of 3 quarters · filed 2021-03-12 | 27.73M shares derived: average of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | 27.02M shares 10-K · filed 2021-03-12 | 26.91M shares derived: average of 2 quarters · filed 2021-03-12 | 26.43M shares derived: average of 3 quarters · filed 2021-03-12 | 26.00M shares derived: average of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | 26.80M shares 10-K · filed 2020-03-05 | 26.14M shares derived: average of 2 quarters · filed 2020-03-05 | 25.66M shares derived: average of 3 quarters · filed 2020-03-05 | 25.37M shares 10-K · filed 2021-03-12 |
| 2018-09-30 | 25.47M shares 10-K · filed 2020-03-05 | 25.09M shares derived: average of 2 quarters · filed 2020-03-05 | 24.89M shares 10-Q · filed 2019-11-07 | 24.65M shares derived: average of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | 24.71M shares 10-K · filed 2020-03-05 | 24.59M shares 10-Q · filed 2019-08-07 | 24.38M shares derived: average of 3 quarters · filed 2020-03-05 | 23.84M shares derived: average of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | 24.48M shares 10-K · filed 2020-03-05 | 24.21M shares derived: average of 2 quarters · filed 2020-03-05 | 23.55M shares derived: average of 3 quarters · filed 2020-03-05 | 22.54M shares derived: average of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | 23.94M shares 10-K · filed 2019-03-07 | 23.09M shares derived: average of 2 quarters · filed 2019-03-07 | 21.89M shares derived: average of 3 quarters · filed 2019-03-07 | 21.00M shares 10-K · filed 2020-03-05 |
| 2017-09-30 | 22.24M shares 10-K · filed 2019-03-07 | 20.87M shares derived: average of 2 quarters · filed 2019-03-07 | 20.00M shares 10-Q · filed 2018-11-05 | 19.54M shares derived: average of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | 19.50M shares 10-K · filed 2019-03-07 | 18.87M shares 10-Q · filed 2018-08-08 | 18.64M shares derived: average of 3 quarters · filed 2019-03-07 | 18.46M shares derived: average of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | 18.23M shares 10-K · filed 2019-03-07 | 18.21M shares derived: average of 2 quarters · filed 2019-03-07 | 18.11M shares derived: average of 3 quarters · filed 2019-03-07 | 18.02M shares derived: average of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | 18.19M shares 10-K · filed 2018-03-08 | 18.05M shares derived: average of 2 quarters · filed 2018-03-08 | 17.95M shares derived: average of 3 quarters · filed 2018-03-08 | 14.62M shares 10-K · filed 2019-03-07 |
| 2016-09-30 | 17.90M shares 10-K · filed 2018-03-08 | 17.83M shares derived: average of 2 quarters · filed 2018-03-08 | 13.42M shares 10-Q · filed 2017-11-08 | 10.07M shares derived: average of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | 17.77M shares 10-K · filed 2018-03-08 | 11.16M shares 10-Q · filed 2017-08-10 | 7.46M shares derived: average of 3 quarters · filed 2018-03-08 | 5.62M shares derived: average of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | 4.54M shares 10-K · filed 2018-03-08 | 2.31M shares derived: average of 2 quarters · filed 2018-03-08 | 1.57M shares derived: average of 3 quarters · filed 2018-03-08 | 1.19M shares derived: average of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | 83.16K shares 10-K · filed 2017-03-14 | 77.40K shares derived: average of 2 quarters · filed 2017-03-14 | 71.53K shares derived: average of 3 quarters · filed 2017-03-14 | 68.35K shares 10-K · filed 2018-03-08 |
| 2015-09-30 | 71.64K shares 10-K · filed 2017-03-14 | 65.71K shares derived: average of 2 quarters · filed 2017-03-14 | 63.36K shares 10-Q · filed 2016-11-14 | |
| 2015-06-30 | 59.79K shares 10-K · filed 2017-03-14 | 59.16K shares 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | 58.52K shares 10-K · filed 2017-03-14 | |||
| 2014-12-31 | 58.18K shares 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |